Fucoidan as a Promising Drug for Pain Treatment: Systematic Review and Meta-Analysis
Marine Drugs · 24.06.2024 · 22 (7) · 290
DOI: 10.3390/md22070290 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Marine Drugs, online erschienen am 24.06.2024. Verfasst von Miguel Á Huerta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Granada, 18016 Granada, Spain. Hauptthemen laut MEDLINE: Polysaccharides, Analgesics, Pain. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Ministry of Economy and Competitiveness (MINECO).
Abstract (Originalsprache)
Fucoidan is a polymer of L-fucose and L-fucose-4-sulphate naturally found in marine sources that inhibits p-selectin, preventing neutrophil recruitment to the site of injury. Fucoidan is employed in many studies as a tool to investigate the contribution of neutrophils to pain, showing analgesic effects. We performed a systematic review and meta-analysis to quantify the analgesic effects of pretreatment with fucoidan reported in the available preclinical studies. In addition, we summarized the articles which have studied the therapeutic effects of fucoidan in pathological pain at preclinical and clinical levels. The results of this systematic review reveal that pretreatment with fucoidan is a powerful tool which reduces neutrophil infiltration by 70–90% at early time points. This meta-analysis showed that preventative treatment with fucoidan produced a significant pain reduction. In addition, several preclinical studies have observed that fucoidan treatment reduces the pain that is associated with various pathologies. Finally, fucoidan has also been tested in several clinical trials, with some degree of analgesic efficacy, but they were mostly small pilot studies. Considering all the above information, it can be concluded that fucoidan is not only a preclinical tool for studying the role of neutrophils in pain but also a promising therapeutic strategy for pain treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of Granada, 18016 Granada, Spain.
- Institute of Neuroscience, Biomedical Research Center, University of Granada, 18016 Granada, Spain.
- Biosanitary Research Institute ibs.GRANADA, 18012 Granada, Spain.
ORCID-Profile: Miguel Á Huerta, Francisco R Nieto
Förderung
- Spanish Ministry of Economy and Competitiveness (MINECO)
Zitieren
APA
Huerta, M. Á., Tejada, M. Á., & Nieto, F. R. (2024). Fucoidan as a Promising Drug for Pain Treatment: Systematic Review and Meta-Analysis. Marine Drugs, 22(7), 290. https://doi.org/10.3390/md22070290
Vancouver
Huerta MÁ, Tejada MÁ, Nieto FR. Fucoidan as a Promising Drug for Pain Treatment: Systematic Review and Meta-Analysis. Marine Drugs. 2024;22(7):290. doi:10.3390/md22070290
BibTeX
@article{Huerta2024,
author = {Huerta, Miguel Á and Tejada, Miguel Á and Nieto, Francisco R},
title = {Fucoidan as a Promising Drug for Pain Treatment: Systematic Review and Meta-Analysis},
journal = {Marine Drugs},
year = {2024},
volume = {22},
number = {7},
pages = {290},
doi = {10.3390/md22070290}
}
EUVIMED